article thumbnail

UCB reports success in phase 3 study of fenfluramine for CDD

Pharma Times

The company is also running an open-label, long-term extension to evaluate safety and tolerability over 52 weeks. Find jobs Download our apps Go to the App Store or Google Play and search for ‘PharmaTimes’ to download our free app. This field is required.

Diabetes 129
article thumbnail

Episode 985: Is the IV or Nebulized Route Better When Giving Tranexamic Acid for Hemoptysis?

Pharmacy Joe

This was an open label randomized trial of 110 patients who were evenly split between IV and nebulized tranexamic acid groups. To get access to my free download area with 20 different resources to help hospital pharmacists go to pharmacyjoe.com/free.

Inpatient 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Health Canada expands Orkambi label to include access to infants

Pharmaceutical Technology

This label expansion makes Orkambi the only disease-modifying CF medication available to patients of this age in Canada. This label expansion follows a similar label change in the US in September 2022. Health Canada is granting this new label expansion based on recent results from a Phase III study.

article thumbnail

Sartorius – Octet Label free detection system

Express Pharma

Real-Time, Label-Free, Stress Free Protein Analysis. The Sartorius Octet® systems, built using label-free Bio-Layer Interferometry (BLI) optical technology, offer a fast, robust and fluidics-free approach to protein analysis. Download the brochure and learn more about the Octet® R Series Systems.

article thumbnail

Pharmaceutical packaging companies and labelling machines

Pharmaceutical Technology

Download our extensive, free list of the leading pharmaceutical packaging companies and labelling machine manufacturers today.

article thumbnail

PBM Industry Update: Trends, Challenges, and What's Ahead (NEW Live Video Webinar)

Drug Channels

Or, download this spreadsheet and email your registrants information to dcisupport@hmpglobal.com. We recommend that every registrant download the Zoom client software/app. Emerging controversies, challenges, and threats to watch in the industry And much more! This link is unique to the registrant and can only be accessed once.

article thumbnail

Overcoming regulatory issues with investigational medicinal product labelling 

Pharmaceutical Technology

Issues with regulatory requirements and documentation can also cause significant delays, while any inaccuracies in translations on labelling can mean that dosage and storage information is not correctly understood or followed. And accurate labelling and translation are critical for this sector.